Every year, the EULAR Congress stands as a beacon of knowledge, bringing together over 12,000 delegates, including rheumatologists, healthcare professionals, and patients from all walks of life. This year, I had the privilege of being a part of this grand event in the vibrant city of Milan. As a member of the Lupus Europe Patient Advisory Network (PAN) and a Board Member of CYLPER, my journey at EULAR 2023 was both exhilarating and profoundly meaningful.

 

 

My excitement soared when my abstract was selected for an oral presentation.The abstract highlighted a unique campaign for World Arthritis Day on October 12, 2022, organised successfully by CYLPER. It was an honour to share our achievements and exchange ideas with professionals and patients from around the globe.

A woman speaking in front of a blue and black podium at EULAR 2023. The podium reads "Chryso Kyriakou Yiasoumi"

 

 

Advocating for Lupus Awareness with Lupus Europe:

As a member of the Cyprus League for people with Rheumatism, I have served as the General Secretary for the past five years. Additionally, my affiliation with the Lupus Cyprus group as a volunteer for over 15 years and my role as a PAN member within Lupus Europe have been deeply enriching experiences. Lupus Europe, an umbrella organisation uniting national organisations across Europe for individuals living with Lupus, has become my extended family.

Lupus, an autoimmune rheumatic chronic disease, can affect people of all ages, predominantly women. One of the critical aspects of advocacy work revolves around creating awareness about the seriousness of Lupus, an often “invisible disease.” At EULAR 2023, I had the privilege to engage with stakeholders, politicians, healthcare professionals, and patients. I emphasised the significance of early diagnosis, proper therapy, and effective disease management.

 

Lupus Europe’s Remarkable Initiatives:

 

The Lupus Europe booth at EULAR 2023 in Milan. Background of a big Lupus Europe banner that covers the back of the picture. Three women standing in front of the Lupus Europe booth table. The table has leaflets and Lupus100 books. One of the women is holding Lupus100 leaflets. On the left hand side of the picture is the Congress corridor. On background of the right hand side of the picture is a chair

During the congress, I dedicated several hours volunteering at the Lupus Europe booth,promoting the Lupus100 project. This project is a multilingual website that offers clear answers to the 100 questions most commonly asked by patients about lupus. It offers those answers in over 10 languages and in doing so bridges the information gap for both patients and professionals. Being part of this initiative was not just fulfilling, but crucial in disseminating accurate information about Lupus.

 

 

 

 

The Lupus Europe Patient Advisory Network: A Source of Happiness amid Challenges

Being a PAN member has opened doors to exciting opportunities. Despite the challenges of living with lupus, the support and camaraderie within this group have been invaluable. At the end of each day at EULAR 2023, Lupus Europe PAN members and Board members gathered to discuss our presentations and posters, reflect on our achievements and prepare for the next day. The sense of organisation and unity within Lupus Europe was truly inspiring.

In conclusion, my journey at EULAR 2023 was a testament to the power of collective advocacy and the strength of unity. Lupus Europe’s PAN has provided me with another platform through which to raise my voice, share my experiences, and contribute meaningfully to the lupus community. Together, we are stronger, spreading awareness, and striving for a future where lupus is not just understood but also effectively managed. The journey continues, and I am grateful to be a part of this remarkable endeavour.

 

By Chryso Yiasoumi, Member of the Lupus Europe Patient Advisory Network (PAN),  Board Member of CYLPER (Cyprus League of People with Rheumatism) and its lupus group and Co-Opt to the Lupus Europe Board of Directors.

 

Live Facebook Feed

Comments Box SVG iconsUsed for the like, share, comment, and reaction icons

☀️ Good morning from beautiful London!

#Eular2026 is here, and so are we‼️

💬 You may already know #lupusgpt. You may have read the paper in The Lancet Rheumatology. You may have tried the tool, shared it with a patient, or recommended it to a colleague.

📊 But there is more. More to do. More lessons learned from two years of building something genuinely patient-led. More to understand about what happens when patients, clinicians, and AI specialists work together from the very first question.

🦋 This week, we will be sharing it all.

#lupusgpt: more than you think. Further than you imagined.
... See MoreSee Less

☀️ Good morning

📅 Tomorrow, the EULAR Congress begins!

🌍 #Eular2026 starts tomorrow, and Lupus Europe will be there!

🦋 We will be representing the patient voice, following the latest research, and sharing key updates with our community throughout the week.

Stay tuned for live updates, session highlights, and much more.

💬 Will you be following the congress? Let us know in the comments!
... See MoreSee Less

📅 Tomorrow, the E

🔴 𝐑𝐞𝐦𝐢𝐬𝐬𝐢𝐨𝐧 𝐝𝐨𝐞𝐬𝐧❜𝐭 𝐚𝐥𝐰𝐚𝐲𝐬 𝐟𝐞𝐞𝐥 𝐥𝐢𝐤𝐞 𝐫𝐞𝐦𝐢𝐬𝐬𝐢𝐨𝐧 🔴

This is one of the most important insights from a new editorial just published in Rheumatology.

📋 The editorial responds to a study analysing five years of data from the Amsterdam SLE cohort. The findings are striking:

🔹 In over half of clinical visits, patients rated their disease as more active than their physicians did.
🔹 Even among visits meeting formal remission criteria, more than 1 in 3 patients still reported significant disease burden.

These discrepancies highlight an important gap between how disease activity is measured clinically and how lupus is experienced by patients in daily life

📊 According to LUPUS EUROPE’s Swiss Knife Survey, patients’ definitions of “disease control” often go far beyond normal blood tests. They include 𝗳𝗿𝗲𝗲𝗱𝗼𝗺 𝗳𝗿𝗼𝗺 𝗳𝗹𝗮𝗿𝗲𝘀, 𝘀𝘁𝗮𝗯𝗹𝗲 𝘁𝗿𝗲𝗮𝘁𝗺𝗲𝗻𝘁, 𝗾𝘂𝗮𝗹𝗶𝘁𝘆 𝗼𝗳 𝗹𝗶𝗳𝗲, and the ability 𝗹𝗶𝘃𝗲 𝗮𝘀 𝗻𝗼𝗿𝗺𝗮𝗹𝗹𝘆 𝗮𝘀 𝗽𝗼𝘀𝘀𝗶𝗯𝗹𝗲.

𝗦𝗵𝗮𝗿𝗲 𝘄𝗶𝘁𝗵 𝘂𝘀 𝘄𝗵𝗮𝘁 𝗿𝗲𝗺𝗶𝘀𝘀𝗶𝗼𝗻 𝗺𝗲𝗮𝗻𝘀 𝗳𝗼𝗿 𝘆𝗼𝘂. Let's make it visible.

The editorial, co-authored by Dr Alvaro Gomez from Karolinska Institutet, and Zoe Karakikla-Mitsakou, LUPUS EUROPE General Secretary, points to several possible ways this might be addressed:

✅ Incorporating patient-reported outcomes into treatment target definitions
✅ Using assessment tools that better integrate patient-reported symptoms
✅ Exploring broader target frameworks that better reflect what meaningful disease control may look like for people living with lupus

This reinforces why people with lupus must be involved from the start in shaping how treatment success is defined, measured, and pursued.

💬 Have you ever been told you are in remission but not felt like it?

Share what remission means for you in the comments. Let’s make it visible.

📖 Read the full editorial: doi.org/10.1093/rheumatology/keag259
... See MoreSee Less

🎉 In six days, we will be at #EULAR2026!

If you haven't heard of EULAR before, it's Europe's largest rheumatology congress 😃.

🌍 Every year in June, EULAR brings together over 13,000 researchers, clinicians, and patient advocates from more than 130 countries, with 170+ scientific sessions.

🦋 Lupus Europe will be there, and we'll be bringing you the latest on lupus from the congress floor.

🎙️ Not only that! Lupus Europe will be an active part of the congress! As in previous years, some of our Board and PAN members will be presenting posters and abstracts, chairing sessions, and taking the stage as speakers.

👀 Stay tuned!
... See MoreSee Less

LUPUS EUROPE Uniting people with Lupus throughout Europe
Send